Daniel Gonzalez Izundegui, MD

Assistant Professor, Medicine

Daniel Izundegui
617.638.8000
801 Massachusetts Ave

Education

  • Tufts University School of Medicine, MD
  • Boston University School of Public Health, MS
  • Macalester College, BA

Publications

  • Published on 10/15/2022

    Gonzalez Izundegui D, Miller PE, Shah RV, Clish CB, Walker ME, Mitchell GF, Gerszten RE, Larson MG, Vasan RS, Nayor M. Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community. Cardiovasc Diabetol. 2022 Oct 15; 21(1):213. PMID: 36243866.

    Read at: PubMed
  • Published on 8/7/2022

    Ghusn W, Cifuentes L, Campos A, Sacoto D, De La Rosa A, Feris F, Calderon G, Gonzalez-Izundegui D, Stutzman J, Hurtado MD, Camilleri M, Acosta A. Association Between Food Intake and Gastrointestinal Symptoms in Patients With Obesity. Gastro Hep Adv. 2023; 2(1):121-128. PMID: 36741967.

    Read at: PubMed
  • Published on 7/26/2022

    Ricardo-Silgado ML, Singh S, Cifuentes L, Decker PA, Gonzalez-Izundegui D, Moyer AM, Hurtado MD, Camilleri M, Bielinski SJ, Acosta A. Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study. BMC Med. 2022 Jul 26; 20(1):261. PMID: 35879764.

    Read at: PubMed
  • Published on 6/21/2022

    Hashem AM, Cifuentes L, Calderon G, Ricardo-Silgado ML, Gonzalez-Izundegui D, Campos A, McRae A, Franks S, Hurtado MD, Burton D, Petterson XM, Lanza IR, Camilleri M, Acosta A. Effect of caloric intake and macronutrient composition on intestinal cholesterol absorption and bile acids in patients with obesity. Am J Physiol Gastrointest Liver Physiol. 2022 Sep 01; 323(3):G157-G164. PMID: 35727128.

    Read at: PubMed
  • Published on 5/5/2022

    McRae A, Ricardo-Silgado ML, Liu Y, Calderon G, Gonzalez-Izundegui D, Rohakhtar FR, Simon V, Li Y, Acosta A. A Protocol for the Cryopreservation of Human Intestinal Mucosal Biopsies Compatible With Single-Cell Transcriptomics and Ex Vivo Studies. Front Physiol. 2022; 13:878389. PMID: 35600311.

    Read at: PubMed
  • Published on 2/3/2022

    Izundegui DG, Nayor M. Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms. Curr Diab Rep. 2022 02; 22(2):65-76. PMID: 35113332.

    Read at: PubMed
  • Published on 11/22/2021

    Calderon G, Gonzalez-Izundegui D, Shan KL, Garcia-Valencia OA, Cifuentes L, Campos A, Collazo-Clavell ML, Shah M, Hurley DL, Abu Lebdeh HS, Sharma M, Schmitz K, Clark MM, Grothe K, Mundi MS, Camilleri M, Abu Dayyeh BK, Hurtado Andrade MD, Mokadem MA, Acosta A. Effectiveness of anti-obesity medications approved for long-term use in a multidisciplinary weight management program: a multi-center clinical experience. Int J Obes (Lond). 2022 Mar; 46(3):555-563. PMID: 34811486.

    Read at: PubMed
  • Published on 7/27/2021

    Gonzalez-Izundegui D, Campos A, Calderon G, Ricardo-Silgado ML, Cifuentes L, Decker PA, Vargas EJ, Tran L, Burton D, Abu Dayyeh B, Camilleri M, Eckel-Passow JE, Acosta A. Association of gastric emptying with postprandial appetite and satiety sensations in obesity. Obesity (Silver Spring). 2021 Sep; 29(9):1497-1507. PMID: 34313001.

    Read at: PubMed
  • Published on 4/22/2021

    Vijayvargiya P, Gonzalez Izundegui D, Calderon G, Tawfic S, Batbold S, Saifuddin H, Duggan P, Melo V, Thomas T, Heeney M, Beyde A, Miller J, Valles K, Oyemade K, Brant JF, Atieh J, Donato LJ, Camilleri M. Increased Fecal Bile Acid Excretion in a Significant Subset of Patients with Other Inflammatory Diarrheal Diseases. Dig Dis Sci. 2022 Jun; 67(6):2413-2419. PMID: 33886031.

    Read at: PubMed
  • Published on 7/1/2020

    Vijayvargiya P, Gonzalez Izundegui D, Calderon G, Tawfic S, Batbold S, Camilleri M. Fecal Bile Acid Testing in Assessing Patients With Chronic Unexplained Diarrhea: Implications for Healthcare Utilization. Am J Gastroenterol. 2020 Jul; 115(7):1094-1102. PMID: 32618660.

    Read at: PubMed

View all profiles